| Security | Market Valueª | Shares or Principal | Investment
Discretion | Other
Managersº | Voting Authority |
|---|
| Issuer Name | Issue Class | Opt. | CUSIP/CINS | $1000s | Weight | Amount | S/P | Price | Sole | Shared | None |
|---|
 | | | | | | | | | ↓List | (S/P Amounts or For All) |
|---|
|
| CRESTWOOD MIDSTREAM PARTNERS | UNIT LTD PARTNER | – | 226378·10·7 | 3,188 | 0.08% | 284,620 | Sh. | 11.20 | Sole | – | Sole | – | – |
| ENERGY TRANSFER EQUITY L P | COM UT LTD PTN | – | 29273V·10·0 | 24,141 | 0.63% | 376,200 | Sh. | 64.17 | Sole | – | Sole | – | – |
| ENERGY TRANSFER PRTNRS L P | UNIT LTD PARTN | – | 29273R·10·9 | 4,052 | 0.11% | 77,634 | Sh. | 52.19 | Sole | – | Sole | – | – |
| ENTERPRISE PRODS PARTNERS L | COM | – | 293792·10·7 | 30,961 | 0.81% | 1,035,834 | Sh. | 29.89 | Sole | – | Sole | – | – |
| FIBROCELL SCIENCE INC | COM NEW | – | 315721·20·9 | 50,695 | 1.33% | 9,619,512 | Sh. | 5.27 | Sole | – | Sole | – | – |
| FIBROCELL SCIENCE INC | COM NEW | – | 315721·20·9 | 31,751 | 0.83% | 6,024,915 | Sh. | 5.27 | Defined | – | Sole | – | – |
| GENESIS ENERGY L P | UNIT LTD PARTN | – | 371927·10·4 | 9,524 | 0.25% | 217,000 | Sh. | 43.89 | Sole | – | Sole | – | – |
| HALOZYME THERAPEUTICS INC | COM | – | 40637H·10·9 | 447,746 | 11.71% | 19,829,337 | Sh. | 22.58 | Sole | – | Sole | – | – |
| HISTOGENICS CORP | COM | – | 43358V·10·9 | 17,381 | 0.45% | 2,690,570 | Sh. | 6.46 | Defined | – | Sole | – | – |
| INTREXON CORP | COM | – | 46122T·10·2 | 3,012,164 | 78.75% | 61,724,682 | Sh. | 48.80 | Sole | – | Sole | – | – |
| MARTIN MIDSTREAM PRTNRS L P | UNIT L P INT | – | 573331·10·5 | 4,390 | 0.11% | 141,800 | Sh. | 30.96 | Sole | – | Sole | – | – |
| NUSTAR ENERGY LP | UNIT COM | – | 67058H·10·2 | 6,914 | 0.18% | 116,500 | Sh. | 59.35 | Sole | – | Sole | – | – |
| ORAGENICS INC | COM NEW | – | 684023·20·3 | 12,109 | 0.32% | 8,838,666 | Sh. | 1.37 | Defined | – | Sole | – | – |
| ORAGENICS INC | COM NEW | – | 684023·20·3 | 1,371 | 0.04% | 1,000,555 | Sh. | 1.37 | Sole | – | Sole | – | – |
| OVASCIENCE INC | COM | – | 69014Q·10·1 | 7,904 | 0.21% | 273,224 | Sh. | 28.93 | Defined | – | Sole | – | – |
| OVASCIENCE INC | COM | – | 69014Q·10·1 | 2,893 | 0.08% | 100,000 | Sh. | 28.93 | Sole | – | Sole | – | – |
| SYNTHETIC BIOLOGICS INC | COM | – | 87164U·10·2 | 24,726 | 0.65% | 8,675,768 | Sh. | 2.85 | Defined | – | Sole | – | – |
| SYNTHETIC BIOLOGICS INC | COM | – | 87164U·10·2 | 10,331 | 0.27% | 3,625,000 | Sh. | 2.85 | Sole | – | Sole | – | – |
| TC PIPELINES LP | UT COM LTD PRT | – | 87233Q·10·8 | 5,529 | 0.14% | 97,000 | Sh. | 57.00 | Sole | – | Sole | – | – |
| TRANSGENOMIC INC | COM NEW | – | 89365K·30·5 | 1,287 | 0.03% | 770,490 | Sh. | 1.67 | Sole | – | Sole | – | – |
| ZIOPHARM ONCOLOGY INC | COM | – | 98973P·10·1 | 115,989 | 3.03% | 9,665,742 | Sh. | 12.00 | Sole | – | Sole | – | – |
| — 17 Issuers — | — 17 Issues — | — 21 Holdings: $3,825,046,000 — | — Sole Manager — |
____________
ª No market value of any Holding was adjusted.
º Other Included Managers with whom investment discretion is shared as to any Holding: No Other Included Managers |
|
